Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Lobe-specific calmodulin binding to different ryanodine receptor isoforms.

Lau K, Chan MM, Van Petegem F.

Biochemistry. 2014 Feb 11;53(5):932-46. doi: 10.1021/bi401502x. Epub 2014 Jan 30.

PMID:
24447242
2.

Regulation of the RYR1 and RYR2 Ca2+ release channel isoforms by Ca2+-insensitive mutants of calmodulin.

Fruen BR, Black DJ, Bloomquist RA, Bardy JM, Johnson JD, Louis CF, Balog EM.

Biochemistry. 2003 Mar 11;42(9):2740-7.

PMID:
12614169
3.

Site-specific modification of calmodulin Ca²(+) affinity tunes the skeletal muscle ryanodine receptor activation profile.

Jiang J, Zhou Y, Zou J, Chen Y, Patel P, Yang JJ, Balog EM.

Biochem J. 2010 Nov 15;432(1):89-99. doi: 10.1042/BJ20100505.

PMID:
20815817
4.

Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor).

Yamaguchi N, Xu L, Pasek DA, Evans KE, Meissner G.

J Biol Chem. 2003 Jun 27;278(26):23480-6. Epub 2003 Apr 21.

5.

Different regions in skeletal and cardiac muscle ryanodine receptors are involved in transducing the functional effects of calmodulin.

Yamaguchi N, Xu L, Evans KE, Pasek DA, Meissner G.

J Biol Chem. 2004 Aug 27;279(35):36433-9. Epub 2004 Jun 23.

6.

Identification of apocalmodulin and Ca2+-calmodulin regulatory domain in skeletal muscle Ca2+ release channel, ryanodine receptor.

Yamaguchi N, Xin C, Meissner G.

J Biol Chem. 2001 Jun 22;276(25):22579-85. Epub 2001 Apr 16.

7.

S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex.

Rebbeck RT, Nitu FR, Rohde D, Most P, Bers DM, Thomas DD, Cornea RL.

J Biol Chem. 2016 Jul 22;291(30):15896-907. doi: 10.1074/jbc.M115.713107. Epub 2016 May 19.

8.

Calmodulin regulation and identification of calmodulin binding region of type-3 ryanodine receptor calcium release channel.

Yamaguchi N, Xu L, Pasek DA, Evans KE, Chen SR, Meissner G.

Biochemistry. 2005 Nov 15;44(45):15074-81.

PMID:
16274254
9.

Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity.

Zhao F, Li P, Chen SR, Louis CF, Fruen BR.

J Biol Chem. 2001 Apr 27;276(17):13810-6. Epub 2001 Feb 5.

10.

Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.

Chen W, Koop A, Liu Y, Guo W, Wei J, Wang R, MacLennan DH, Dirksen RT, Chen SRW.

Biochem J. 2017 Aug 7;474(16):2749-2761. doi: 10.1042/BCJ20170282.

PMID:
28687594
11.

Calmodulin-binding locations on the skeletal and cardiac ryanodine receptors.

Huang X, Fruen B, Farrington DT, Wagenknecht T, Liu Z.

J Biol Chem. 2012 Aug 31;287(36):30328-35. doi: 10.1074/jbc.M112.383109. Epub 2012 Jul 6.

12.

Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor).

Balshaw DM, Xu L, Yamaguchi N, Pasek DA, Meissner G.

J Biol Chem. 2001 Jun 8;276(23):20144-53. Epub 2001 Mar 27.

13.

Loss of the calmodulin-dependent inhibition of the RyR1 calcium release channel upon oxidation of methionines in calmodulin.

Boschek CB, Jones TE, Smallwood HS, Squier TC, Bigelow DJ.

Biochemistry. 2008 Jan 8;47(1):131-42. Epub 2007 Dec 13.

PMID:
18076146
14.

Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.

Gomez AC, Holford TW, Yamaguchi N.

Am J Physiol Cell Physiol. 2016 Nov 1;311(5):C749-C757. doi: 10.1152/ajpcell.00134.2016. Epub 2016 Aug 24.

15.

Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.

Meissner G, Pasek DA, Yamaguchi N, Ramachandran S, Dokholyan NV, Tripathy A.

Proteins. 2009 Jan;74(1):207-11. doi: 10.1002/prot.22148.

16.

The carboxy-terminal calcium binding sites of calmodulin control calmodulin's switch from an activator to an inhibitor of RYR1.

Rodney GG, Krol J, Williams B, Beckingham K, Hamilton SL.

Biochemistry. 2001 Oct 16;40(41):12430-5.

PMID:
11591164
17.

Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.

Murayama T, Kurebayashi N, Ogawa H, Yamazawa T, Oyamada H, Suzuki J, Kanemaru K, Oguchi K, Iino M, Sakurai T.

Hum Mutat. 2016 Nov;37(11):1231-1241. doi: 10.1002/humu.23072. Epub 2016 Sep 19.

PMID:
27586648
18.

Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.

O'Driscoll S, McCarthy TV, Eichinger HM, Erhardt W, Lehmann-Horn F, Herrmann-Frank A.

Biochem J. 1996 Oct 15;319 ( Pt 2):421-6.

20.

Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin.

Fruen BR, Bardy JM, Byrem TM, Strasburg GM, Louis CF.

Am J Physiol Cell Physiol. 2000 Sep;279(3):C724-33.

PMID:
10942723

Supplemental Content

Support Center